Top compounds associated with response to C22orf31

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	CHIR-99021	GDSC1000	pan-cancer	AAC	-0.075	0.02
mRNA	SKI-II	CTRPv2	pan-cancer	AAC	0.086	0.02
mRNA	alisertib:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.081	0.02
mRNA	BRD1812	CTRPv2	pan-cancer	AAC	0.082	0.02
mRNA	BRD-K85133207	CTRPv2	pan-cancer	AAC	0.086	0.02
mRNA	ZSTK474	CTRPv2	pan-cancer	AAC	0.086	0.02
mRNA	ABT-263	CTRPv2	pan-cancer	AAC	0.08	0.02
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.076	0.03
mRNA	Doxorubicin	FIMM	pan-cancer	AAC	-0.33	0.03
mRNA	tacrolimus	CTRPv2	pan-cancer	AAC	0.078	0.03

Download CSV